Persistence of use of lipid-lowering medications: A cross-national study

JAMA

Volumn 279, Issue 18, 1998, Pages 1458-1462

  Avorn, Jerry ^a,c   Monette, Johanne ^a   Lacour, Anne ^b   Bohn, Rhonda L ^a   Monane, Mark ^a   Mogun, Helen ^a   LeLorier, Jacques ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CLOFIBRATE; COLESTIPOL; COLESTYRAMINE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; PROBUCOL; SIMVASTATIN;

ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0032513736     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.18.1458     Document Type: Article

References (30)

1. Andrade SE, Walker AM, Gottlieb LK, et al. Discontinuation of antihyperlipidemic drugs. N Engt J Med. 1995;332:1125-1131.
2. Oster G, Borok GM, Menzin J, et al. Cholesterol-Reduction Intervention Study (CRIS). Arch Intern Med. 1996;156:731-739.
3. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? JAMA. 1989;261:3273-3277.
4. Monane M, Bohn R, Gurwitz JH, Glynn RJ, Avorn J Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 1994;154:433-437
5. Salzman C. Medication compliance in the elderly. J Clin Psychiatry. 1995;56(suppl 1):18-22.
6. American College of Physicians. Guidelines for using serum cholesterol, high-density hpoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med. 1996;124:515-517.
7. Krumholz HM, Seeman TE, Merrill SS, et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA. 1994;272:1335-1340.
8. Hulley SB, Newman TB. Cholesterol in the elderly: is it important? JAMA. 1994;272:1372-1374.
9. Sacks FM. The effect of pravastatm on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335: 1001-1009.
10. Bright RA, Avorn J, Everitt DE. Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol. 1989;42:937-945.
11. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. N Engl J Med. 1983;308:1457-1463.
12. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol. 1989;129: 837-849
13. Taniblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims database in pharmacoepidemiological research. J Clin Epidemiol. 1995; 48:999-1009.
14. Cox DR. Analysis of Binary Data. London, England: Chapman & Hall; 1990.
15. SAS Institute Inc. The CATMOD procedure. In: SAS/STAT User's Guide. Release 6.03. Cary, NC: SAS Institute Inc; 1988:405-517.
16. Rosner B. Hypothesis testing: categorical data. In: Fundamentals of Biostatistics. Boston, Mass: PWS Publishers; 1986:302-367.
17. Caron HS, Roth HP. Patients' cooperation with a medical regimen. JAMA. 1968;203:922-926.
18. Evans L, Spelman M. The problem of noncompliance with drug therapy. Drugs. 1983;25:63-76.
19. Efron B, Fedman D. Compliance as an explanatory variable in clinical trials. JAm Stat Assoc. 1991; 86(413):9-26.
20. National Council on Patient Information and Education. Talk About Information and Education. Washington, DC: National Council on Patient Information and Education; 1990.
21. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees. Am J Public Health. 1996;86:1805-1808.
22. Bradford RH, Shear CL, Chremos AN, et al. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results, I. Arch Intern Med. 1991;
23. Mellies MJ, DeVault AR, Kassler-Taub K, McGovern ME, Pan HY. Pravastatin experience in elderly and non-elderly patients. Atherosclerosis. 1993;101:97-110.
24. LaRosa JC, Applegate W, Crouse JR III, et al. Cholesterol lowering in the elderly. Arch Intern Med. 1994;154:529-539. .
25. Stephenson BJ, Rowe BH, Haynes B, Machana WM Leon G. Is this patient taking the treatment as prescribed? JAMA. 1993;269:2779-2781.
26. Rosenstock IM. Adoption and maintenance of life-style modifications. Am J Prev Med. 1988;4:349-352
27. Spaeth GL. Visual loss in a glaucoma clinic, I. Invest Ophthalmol. 1970;9:73-82.
28. Hershey JC, Morton BG, Davis JB, Reichgott MJ Patient compliance with antihypertensive medication. Am J Public Health. 1980;70:1081-1089
29. Glickman L, Bruce EA, Caro FG, Avorn J. Physicians' knowledge of drug costs for the elderly. J Am Geriatr Soc. 1994;42:992-996.
30. Donovan JL. Patient decision making: the missing ingredient in compliance research. Int J Technol Assess Health Care. 1995;11:443-455.